Panel clarifies BRCA screening recommendations
6th Sep 2005, 20:53 GMT
NEW YORK (Reuters Health) - A new statement from the US Preventive Services Task Force recommends against routine testing for mutations in the BRCA1 and BRCA2 genes linked to breast and ovarian cancer unless women have a suggestive family history.
Latest news from Reuters: Health:
- Camel milk ice cream to help trim Indian waists
- Diseased gums raise risk of pancreatic cancer
- FDA staff urges new caution on Roche flu drug
- Simple steps can speed heart attack care: study
- Children showing hardening of arteries: U.S. study
- Antibodies destroy HIV-infected cells
- New drug comb may lengthen ovarian cancer survival
- FDA OKs Genentech drug for early breast cancer
- Drug switch improves breast cancer survival: study